Home  |  Contact  |  Sitemap  |  Chinese  |  CAS

Position in International Organization

  • Lu Xueying  / 
  • Education:
    Direction:  
  • E-mail: xueyinglu@ms.xjb.ac.cn
    Postal Code: 830011
  • Address: Technical Institute of Physics & Chemistry Chinese Academy of Sciences 40-1 South Beijing Road Urumqi, Xinjiang 830011 China
Resume

 Lu Xuying engaged in the research and development of molecular pharmacology and ethnic medicines. Presided or participated in scientific research projects such as the Light of the West Program, the Youth Science Fund of the Autonomous Region, and the Key R&D Program of the Autonomous Region. Participated in the development of 1 product, and published more than 30 papers.

2007  2020 The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Science, Assistant Professor; 

2011-2015  Xinjiang University, Ph. D of Zoology; 

2021- until The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Science, Associate Professor; 

 

Research Areas and Achievements 

Research work is concentrated on molecular pharmacology and ethnic medicines, and studies mainly for evaluation of the activity of ethnic medicines against vitiligo, tumors and other diseases.  

 

 Selected Honor 

2011 The third prize of science and Technology Progress Award in Xinjiang; 

2019 The National Advanced Workers by The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Science; 

2020 The National Advanced Workers by The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Science; 

2021 The National Advanced Workers by The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Science; 

  

Representative Publications  

1. Changhua Liu, Atikanmu Wahefu, Xueying Lu, Rahima Abdulla, Jun Dou, Haiqing Zhao, Haji Akber Aisa, Xuelei Xin, Yongqiang Liu, Chemical Profiling of Kaliziri Injection and Quantification of Six Caffeoyl Quinic Acids in Beagle Plasma by LC-MS/MS, Pharmaceuticals, 2022, 15, 663. 

2. Abuduaini A, Lu Xueying, Zang Deng, Wu Tao, Aisa HA. Effects of a Traditional Caraway Formulation on Experimental Models of Vitiligo and Mechanisms of Melanogenesis. Evid Based Complement Alternat Med. 2021, 2021:6675657. 

3. Xueying Lu, Jun Dou, Haji Akber Aisa. Real-time PCR assays for detection of melanogenesis-related genes from Chinese traditional medicine components, European Journal of Integrative Medicine, 2018, 23: 70-76. 

4. Xueying Lu,Yanhong Li, Xiaobo Li, Haji Akber Aisa. Luteolin induces apoptosis in vitro through suppressing MAPK and PI3K signaling pathway in gastric cancer, Oncology Letters, 2017, 14(2):1993-2000. 

5. Chao Niu, Xueying Lu, Haji Akber Aisa. Preparation of novel 1,2,3-triazole furocoumarin derivatives via click chemistry and their anti-vitiligo activity. RSC Advances, 2019, 9, 1671–1678. 

6. Nuramina Mamat, Xueying Lu, Maidina Kabas, Haji Akber Aisa. Potential anti-vitiligo properties of cynarine extracted from Vernonia anthelmintica (L.) Willd, International Journal of Molecular Medicine, 2018, 42: 2665-2675. 

7. Qing Ren, Xueying Lu, Jianxin Han, Haji Akber Aisa, Tao Yuan. Triterpenoids and phenolics from the fruiting bodies of Inonotus hispidus and their activations of melanogenesis and tyrosinase, Chinese chimical letter, 2017, 28 (5): 1052-1056. 

8. Nuramina Mamat, Dou Jun, Lu Xueying, Yin Li, Eblimit Aiden, Aisa Haji Akber. Isochlorogenic acid A promotes melanin contents in B16 cell through Wnt/β-catenin signal pathway, Acta Biochimica et Biophysica Sinica, 2017, 49(9):800-807. 

9. Yanhong Li, Hongxue Qi, Xiaobo Li, Xueling Hou, Xueying Lu, Xiangwen Xiao. A Novel Dithiocarbamate Derivative Induces Cell Apoptosis Through P53-Dependent Intrinsic Pathway and Suppresses the Expression of the E6 Oncogene of Human Papillomavirus 18 in HeLa cells. Apoptosis, 2015, 20:787–795. 

10.Yanhong Li, Xueying Lu, Hongxue Qi, Xiaobo Li, Xiangwen Xiao, and Jianfeng Gao. Ursolic Acid Induces Apoptosis Through Mitochondrial Intrinsic Pathway and Suppression of ERK1/2 MAPK in HeLa Cells, Journal of Pharmacological Sciences, 2014, 125, 202–210. 

  

Representative Patents 

A kind of psoralen derivative containing phenyltriazole and application, invention patent, authorization number: ZL201710995086.X 

 

Research area:  

 Molecular pharmacology and ethnic medicine 

Commitment to research the situation

 Lu Xuying engaged in the research and development of molecular pharmacology and ethnic medicines. Presided or participated in scientific research projects such as the Light of the West Program, the Youth Science Fund of the Autonomous Region, and the Key R&D Program of the Autonomous Region. Participated in the development of 1 product, and published more than 30 papers.

2007  2020 The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Science, Assistant Professor; 

2011-2015  Xinjiang University, Ph. D of Zoology; 

2021- until The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Science, Associate Professor; 

 

Research Areas and Achievements 

Research work is concentrated on molecular pharmacology and ethnic medicines, and studies mainly for evaluation of the activity of ethnic medicines against vitiligo, tumors and other diseases.  

 

 Selected Honor 

2011 The third prize of science and Technology Progress Award in Xinjiang; 

2019 The National Advanced Workers by The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Science; 

2020 The National Advanced Workers by The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Science; 

2021 The National Advanced Workers by The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Science; 

  

Representative Publications  

1. Changhua Liu, Atikanmu Wahefu, Xueying Lu, Rahima Abdulla, Jun Dou, Haiqing Zhao, Haji Akber Aisa, Xuelei Xin, Yongqiang Liu, Chemical Profiling of Kaliziri Injection and Quantification of Six Caffeoyl Quinic Acids in Beagle Plasma by LC-MS/MS, Pharmaceuticals, 2022, 15, 663. 

2. Abuduaini A, Lu Xueying, Zang Deng, Wu Tao, Aisa HA. Effects of a Traditional Caraway Formulation on Experimental Models of Vitiligo and Mechanisms of Melanogenesis. Evid Based Complement Alternat Med. 2021, 2021:6675657. 

3. Xueying Lu, Jun Dou, Haji Akber Aisa. Real-time PCR assays for detection of melanogenesis-related genes from Chinese traditional medicine components, European Journal of Integrative Medicine, 2018, 23: 70-76. 

4. Xueying Lu,Yanhong Li, Xiaobo Li, Haji Akber Aisa. Luteolin induces apoptosis in vitro through suppressing MAPK and PI3K signaling pathway in gastric cancer, Oncology Letters, 2017, 14(2):1993-2000. 

5. Chao Niu, Xueying Lu, Haji Akber Aisa. Preparation of novel 1,2,3-triazole furocoumarin derivatives via click chemistry and their anti-vitiligo activity. RSC Advances, 2019, 9, 1671–1678. 

6. Nuramina Mamat, Xueying Lu, Maidina Kabas, Haji Akber Aisa. Potential anti-vitiligo properties of cynarine extracted from Vernonia anthelmintica (L.) Willd, International Journal of Molecular Medicine, 2018, 42: 2665-2675. 

7. Qing Ren, Xueying Lu, Jianxin Han, Haji Akber Aisa, Tao Yuan. Triterpenoids and phenolics from the fruiting bodies of Inonotus hispidus and their activations of melanogenesis and tyrosinase, Chinese chimical letter, 2017, 28 (5): 1052-1056. 

8. Nuramina Mamat, Dou Jun, Lu Xueying, Yin Li, Eblimit Aiden, Aisa Haji Akber. Isochlorogenic acid A promotes melanin contents in B16 cell through Wnt/β-catenin signal pathway, Acta Biochimica et Biophysica Sinica, 2017, 49(9):800-807. 

9. Yanhong Li, Hongxue Qi, Xiaobo Li, Xueling Hou, Xueying Lu, Xiangwen Xiao. A Novel Dithiocarbamate Derivative Induces Cell Apoptosis Through P53-Dependent Intrinsic Pathway and Suppresses the Expression of the E6 Oncogene of Human Papillomavirus 18 in HeLa cells. Apoptosis, 2015, 20:787–795. 

10.Yanhong Li, Xueying Lu, Hongxue Qi, Xiaobo Li, Xiangwen Xiao, and Jianfeng Gao. Ursolic Acid Induces Apoptosis Through Mitochondrial Intrinsic Pathway and Suppression of ERK1/2 MAPK in HeLa Cells, Journal of Pharmacological Sciences, 2014, 125, 202–210. 

  

Representative Patents 

A kind of psoralen derivative containing phenyltriazole and application, invention patent, authorization number: ZL201710995086.X 

 

Research area:  

 Molecular pharmacology and ethnic medicine 

(86) 991-3838931
lhskj@ms.xjb.ac.cn
(86)991-3838957
40-1 Beijing Road Urumqi, XinjiangChina